I AM Healthy Money

Inside Vladimir Putin’s reported $26 billion pursuit of longevity lies a mix of science, ambition, and national strategy — from genetically engineered mini-pigs and organ printing to cryotherapy and advanced genetic research. This episode links that cultural fascination with a practical, operational view of longevity: using prescriptive analytics and real-time guidance to extend the life of both m...

In a single episode we trace how housing shortfalls, soaring insurance and retirement costs, and breakthroughs in weight-loss and longevity medicine connect into one big affordability problem. We explore why home construction lags, why premiums are exploding, why retirees tap home equity, how new multi-hormone drugs promise dramatic weight loss, and why Silicon Valley is treating aging like an eng...

On an ordinary day life can pivot—this episode urges you to stop postponing the important: ten specific, heartfelt lines to say to your mom while you still can, and how those small truths bring real closure. It also connects sleeping better, using empathy to end arguments, and a surprising study showing the brain’s hidden language processing under anesthesia—all pointing to one theme: time matters...

Longevity travel is booming and splits into two clear paths: Blue Zone immersion—experiential trips that teach healthier rhythms through place, movement, food, and social connection—and clinical longevity retreats—medical, diagnostics-driven programs that measure biomarkers and deliver targeted interventions. Choose the lane that matches your goals, budget, and tolerance for intervention: adopt li...

Kimberly breaks down modern reverse mortgages—what’s changed, who they help, and why "paying cash" isn’t always the safest choice in retirement. Through stories, data, and clear guidance, learn when a HECM for Purchase or a reverse mortgage line of credit can preserve liquidity, reduce risk, and support smarter retirement moves.

This episode explores how rising life expectancy is forcing a rethink of money, health and everyday services. From UK life-table projections that make 100 a realistic outcome for many born in 2049, to touring artists managing post-show crashes, to hotels and clinics redesigning menus and services for recovery and longevity, the show connects big-picture policy challenges with practical, human stra...

Late-week geopolitics derail a calm market: Iran’s rejected counterproposal lifts oil prices, reigniting inflation fears and pushing bond yields and mortgage rates higher after a five-day rally. Amid the market noise, Longbridge Financial posts a staggering Q1 profit that reshapes investor expectations, while investors also pour money into longevity plays—from inflammation research and regenerativ...

This episode ties together one week where AI, housing and longevity collided: a headline-grabbing claim that Trump could be remembered as the "AI President," OpenAI employees suddenly able to cash out life-changing sums, and a housing market wobbling around 6.4% mortgages with refis and applications falling. We unpack the small-but-significant moves in rates, steady unemployment, tight inventory a...

Walk through a night in New York where a glittering skincare launch sits beside deeper questions: is longevity the new luxury? This episode takes a wide-angle view — from glamorous beauty campaigns and thymus research to coffee science, mortgage strain on older homeowners, and Microsoft’s push to revive a nuclear site to power AI. We explore how lifespan trends touch culture, finance, healthcare,...

Discover how the wellness world is redefining aging, the latest longevity beauty launches, and surprising biohacks—then pivot to a fast-moving week in finance where geopolitical tensions drove mortgage rates above 6.5%, reshaping homebuying, refinancing, and lender behavior. Learn how borrowers adapt with down payment help, home equity strategies, and why accurate information matters more than eve...

A terracotta bowl on a Pompeii victim becomes the entry point for a wide-ranging episode about what happens when extraordinary AI capabilities meet slow institutions and messy human incentives. We cover medical AI that can flag deadly disease from an eye scan, the problem of models learning from low-quality data, the Pentagon’s push to go "AI-first," and Wall Street’s hunt for real AI winners vers...

Late‑night at the kitchen table, retirees are asking the same urgent question: how do I turn my home into the cash I need to live? This episode breaks down why private reverse mortgages have, for the first time, outpaced the government‑insured HECKUM program, why HELOC denials are pushing more seniors toward equity solutions, and how lenders are shifting from products to cash‑flow problem solving....

iamhealthymoney.com Wake up to the booming business of living better: from stress‑soothing ashwagandha and heart‑mind research to experimental drugs like rapamycin and Miami high‑rises that sell longevity as a lifestyle. This episode ties supplements, science, real estate, and ethics into one fast‑moving story about how we try to stretch health and time. Alongside the hype, we unpack real money ma...

Mortgage and housing are changing at once — AI is moving from buzzword to operational necessity, a $124 trillion intergenerational wealth transfer is reshaping client relationships, and markets feel steady on the surface while shifting underneath. This episode traces the collision of those forces: lenders racing to automate wisely, families navigating estate-related home transitions, retirees tapp...

Imagine two people chasing a longer life—one with ice baths and IV drips, the other laughing with friends on a porch. This episode cuts through the longevity gold rush, showing how rapamycin can blunt exercise gains, how AI is accelerating drug discovery and brain imaging, and why mitochondria and muscle health may underlie burnout and metabolic disease. We also tour the week’s wild headlines—from...

Today’s episode stitches two big shifts together: a seismic real-estate move — Real’s $880M deal for RE/MAX and the industry’s rush to scale, integrate fintech, and cut costs — alongside urgent housing stresses from wildfires, mortgage-relief changes, Ginnie Mae reporting tweaks, and new broker platforms pushing tech-forward lending. We also dive into longevity: AI-driven drug discovery, research...

Two worlds collide: breakthrough longevity research promising cellular rejuvenation and a jittery housing market where mortgage rates change your plans overnight. Both stories ask the same question—act now, or wait? The episode walks through the hopeful science—industry growth, organ-specific aging, hibernation studies, and the surprising protective power of community, strength training, and even...

Scientists are reframing aging not as inevitable wear and tear but as "corrupted software" — meaning we might be able to reset biological instructions to prevent Alzheimer’s, heart disease, and other chronic illnesses rather than treating them after they arrive. That shift could transform individual lives and economies: fewer costly, debilitating final years, more productive healthy decades, and a...

Two worlds collide: the slow, systemic influence of education on lifespan and the fast-moving frontiers of anti-aging science and AI. This episode explores a global study linking schooling to longer lives, a contentious gene-therapy “vaccine” trial in Russia, the launch of the world’s first PhD in longevity medicine, and the mainstreaming of longevity services. It also follows AI’s march from secr...

Kimberly connects two fast-moving but easy-to-miss worlds: housing and health. Mortgage rates are easing and buyers gain leverage, but true advantage comes from diligence—aim for a top-tier FICO (780+), mind the fine print, and choose renovation financing carefully instead of rushing into bad deals. On the health side, silent problems—B12 deficiency, kidney disease, and quiet heart attacks—often p...

Mortgage rates have dipped, buyers are re-entering the market, and Fannie Mae/Freddie Mac’s acceptance of VantageScore is loosening who can qualify—yet markets remain wildly local and foreclosures are ticking up. Homeowners are weighing life changes against rate math, banks face office-loan pressure, and tapping home equity is back on the table. The episode connects these money shifts to the perso...

What does success look like when nobody is watching? This episode explores private standards—integrity, consistency, and identity—and how they shape business, relationships, and mental health. Tony Robbins’ three core beliefs (learn your way through anything, build consistent systems, and create market-worthy value) are translated into practical habits that carry you through uncertainty. We connec...

Four stories, one theme: systems shape our days. A builder uses software to shave a month off construction timelines; California debates a bill that raises scary questions about taxing retirement funds; Kew Gardens hosts faith retreats that slow life down; and hospitals are testing AI to make care feel more human. Across speed, security, stillness, and support, the episode asks where better system...

The 30-year mortgage rate finally nudges down to 6.33%, giving homebuyers a cautious sigh of relief and proving even small moves can shift market sentiment. We also break down LeBron’s next-level recovery routine that keeps him elite at 41, Bezos’s hush-hush AI venture Prometheus hitting a $38 billion valuation, and the rapid rise of Iron Valley Real Estate to a $2 billion brokerage—different stor...

This episode threads five headlines into one story: a mortgage firm says AI handles 94% of the work and lays off staff, CEOs report little productivity gain, a Stanford study warns China is surging ahead, an AI-generated dog photo is used in a ransom attempt, and data centers eye the ocean to cool huge machine workloads. The throughline is contradiction — AI as miracle, disappointment, threat, and...